相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b-4 CKD
Pablo E. Pergola et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
Michael B. Sporn et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Pirfenidone for Diabetic Nephropathy
Kumar Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?
Macaulay A. C. Onuigbo
NEPHRON CLINICAL PRACTICE (2011)
Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1
Qing Qing Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Leprdb/db Mice
Pradip K. Saha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
P. Stenvinkel
JOURNAL OF INTERNAL MEDICINE (2010)
Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
Deepti Malhotra et al.
NUCLEIC ACIDS RESEARCH (2010)
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
Sankar D. Navaneethan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
NADPH oxidases and angiotensin II receptor signaling
Abel Martin Garrido et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
P. Fioretto et al.
DIABETOLOGIA (2008)
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
Victoria Cachofeiro et al.
KIDNEY INTERNATIONAL (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice
William O. Osburn et al.
TOXICOLOGICAL SCIENCES (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Anti hypertensive therapy in the presence of proteinuria
Pantelis A. Sarafidis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes
Melinda S. Yates et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179
Rehan Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2
Qiang Ma et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic - A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
M Rahman et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation
M Kobayashi et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Angiotensin II-Induced Signaling Pathways in Diabetes
Mario B. Marrero et al.
CURRENT DIABETES REVIEWS (2005)
Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products
AL Levonen et al.
BIOCHEMICAL JOURNAL (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice
J Li et al.
PHYSIOLOGICAL GENOMICS (2004)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
AH Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12),(14)-prostaglandin J(2)
K Itoh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Leptin and renal disease
G Wolf et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Nrf2-deficient female mice develop lupus-like autoimmune nephritis
K Yoh et al.
KIDNEY INTERNATIONAL (2001)
Pathogenesis of diabetic nephropathy
AE Raptis et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
15-deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
DS Straus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Evolution of incipient nephropathy in type 2 diabetes mellitus
KV Lemley et al.
KIDNEY INTERNATIONAL (2000)
分享论文
